Terms: = Cervical cancer AND PSA AND Treatment
21 results:
1. Complete paraplegia with diffuse osteolytic skeletal metastases: an uncommon presentation of carcinoma of the prostate.
Gupta A; Gahlot N; Elhence P
Spinal Cord Ser Cases; 2020 Apr; 6(1):25. PubMed ID: 32321926
[TBL] [Abstract] [Full Text] [Related]
2. [Delay in High-Grade Metastatic Prostate cancer Progression by Dutasteride : A Case Report].
Yamada Y; Fujiwara H; Somiya S; Fujikawa S; Kamiyama Y; Tamaki M; Kanaoka T
Hinyokika Kiyo; 2018 Apr; 64(4):187-192. PubMed ID: 29772622
[TBL] [Abstract] [Full Text] [Related]
3. Diagnosis and management of metastatic neoplasms with unknown primary.
Bochtler T; Löffler H; Krämer A
Semin Diagn Pathol; 2018 May; 35(3):199-206. PubMed ID: 29203116
[TBL] [Abstract] [Full Text] [Related]
4. Threshold cost-effectiveness analysis for a therapeutic vaccine against HPV-16/18-positive cervical intraepithelial neoplasia in the Netherlands.
Luttjeboer J; Setiawan D; Cao Q; Cahh Daemen T; Postma MJ
Vaccine; 2016 Dec; 34(50):6381-6387. PubMed ID: 27816370
[TBL] [Abstract] [Full Text] [Related]
5. Potential of sulfasalazine as a therapeutic sensitizer for CD44 splice variant 9-positive urogenital cancer.
Takayama T; Kubo T; Morikawa A; Morita T; Nagano O; Saya H
Med Oncol; 2016 May; 33(5):45. PubMed ID: 27044355
[TBL] [Abstract] [Full Text] [Related]
6. Risk of virus-associated cancer in female arthritis patients treated with biological DMARDs-a cohort study.
Cordtz R; Mellemkjær L; Glintborg B; Hetland ML; Madsen OR; Jensen Hansen IM; Dreyer L
Rheumatology (Oxford); 2016 Jun; 55(6):1017-22. PubMed ID: 26912584
[TBL] [Abstract] [Full Text] [Related]
7. [A CASE OF PROSTATE cancer WITH UNUSUAL PATTERN OF RECURRENCE AFTER RADIOTHERAPY].
Oshinomi K; Fukagai T; Ogawa Y; Sato N; Morita J; Aso T; Igarashi A; Morita M; Naoe M; Fuji K; Ogawa Y
Nihon Hinyokika Gakkai Zasshi; 2015 Jan; 106(1):40-4. PubMed ID: 26399130
[TBL] [Abstract] [Full Text] [Related]
8. Adaptive Mathematical Model of Tumor Response to Radiotherapy Based on CBCT Data.
Belfatto A; Riboldi M; Ciardo D; Cecconi A; Lazzari R; Jereczek-Fossa BA; Orecchia R; Baroni G; Cerveri P
IEEE J Biomed Health Inform; 2016 May; 20(3):802-809. PubMed ID: 26173223
[TBL] [Abstract] [Full Text] [Related]
9. The improved accuracy of planar bone scintigraphy by adding single photon emission computed tomography (SPECT-CT) to detect skeletal metastases from prostate cancer.
McLoughlin LC; O'Kelly F; O'Brien C; Sheikh M; Feeney J; Torreggiani W; Thornhill JA
Ir J Med Sci; 2016 Feb; 185(1):101-5. PubMed ID: 25394725
[TBL] [Abstract] [Full Text] [Related]
10. Clinico-pathologic characterisation of metastatic prostate cancer in the Radiotherapy and Oncology Department, Ahmadu Bello University Teaching Hospital, Zaria-Nigeria: 2006-2009.
Adewuyi SA; Mbibu NH; Samaila MO; Ketiku KK; Durosinmi-Etti FA
Niger Postgrad Med J; 2013 Mar; 20(1):45-51. PubMed ID: 23661210
[TBL] [Abstract] [Full Text] [Related]
11. [Auto-dendritic cell vaccines pulsed with psa, PSMA and PAP peptides for hormone-refractory prostate cancer].
Zhuang ZX; Shen LQ; Shi Y; Lu X; Shi HZ
Zhonghua Nan Ke Xue; 2010 Aug; 16(8):698-704. PubMed ID: 21090344
[TBL] [Abstract] [Full Text] [Related]
12. Prostate cancer metastases to bone: observational study for the evaluation of clinical presentation, course and treatment patterns. Presentation of the METAURO protocol and of patient baseline features.
Conti G; La Torre G; Cicalese V; Micheletti G; Ludovico MG; Vestita GD; Cottonaro G; Introini C; Cecchi M
Arch Ital Urol Androl; 2008 Jun; 80(2):59-64. PubMed ID: 18683811
[TBL] [Abstract] [Full Text] [Related]
13. Docetaxel and carboplatin combination chemotherapy as outpatient palliative therapy in carcinoma of unknown primary: a multicentre Hellenic Cooperative Oncology Group phase II study.
Pentheroudakis G; Briasoulis E; Kalofonos HP; Fountzilas G; Economopoulos T; Samelis G; Koutras A; Karina M; Xiros N; Samantas E; Bamias A; Pavlidis N;
Acta Oncol; 2008; 47(6):1148-55. PubMed ID: 18607872
[TBL] [Abstract] [Full Text] [Related]
14. [Prostatic carcinoma that arose with hearing loss: a case report].
Sakuma T; Yoshida T; Ohashi H; Nishimura K; Kawano K
Hinyokika Kiyo; 2007 Jun; 53(6):413-6. PubMed ID: 17628942
[TBL] [Abstract] [Full Text] [Related]
15. Personalized peptide vaccines: a new therapeutic modality for cancer.
Itoh K; Yamada A
Cancer Sci; 2006 Oct; 97(10):970-6. PubMed ID: 16984371
[TBL] [Abstract] [Full Text] [Related]
16. Thermal monitoring: invasive, minimal-invasive and non-invasive approaches.
Wust P; Cho CH; Hildebrandt B; Gellermann J
Int J Hyperthermia; 2006 May; 22(3):255-62. PubMed ID: 16754347
[TBL] [Abstract] [Full Text] [Related]
17. Presentation of prostate carcinoma with cervical lymphadenopathy: report of three cases.
Wang HJ; Chiang PH; Peng JP; Yu TJ
Chang Gung Med J; 2004 Nov; 27(11):840-4. PubMed ID: 15796261
[TBL] [Abstract] [Full Text] [Related]
18. [A case report of distant lymph nodes metastases from prostate cancer imaged with 201Tl and 99mTc-MIBI].
Ikekubo K; Hino M; Ito H; Ohtsuka H; Saiki Y
Kaku Igaku; 2003 Nov; 40(4):439-43. PubMed ID: 14733108
[TBL] [Abstract] [Full Text] [Related]
19. [Diagnostic management of inaugurable metastases].
Penel N
Presse Med; 2003 Jun; 32(21):990-6, 1004. PubMed ID: 12876530
[TBL] [Abstract] [Full Text] [Related]
20. European best practice guidelines for renal transplantation. Section IV: Long-term management of the transplant recipient. IV.6.3. cancer risk after renal transplantation. Solid organ cancers: prevention and treatment.
EBPG Expert Group on Renal Transplantation
Nephrol Dial Transplant; 2002; 17 Suppl 4():32, 34-6. PubMed ID: 12091641
[TBL] [Abstract] [Full Text] [Related]
[Next]
